GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
5.7k
c/trialwatch·posted 10 months ago by u/rulebook_rachael

what would you tell week-1 you about SURMOUNT

Trial Data Receipts ×2 Long Haul ×3 Well Actually ×3

Right, the SURMOUNT question again, but with numbers this time.

I have 19 data points over 32 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.

The thing I would flag for anyone new: the effect I am describing showed up at week 29, not week 78. People give up long before the interesting part.

Interested in whether this matches other people's logs or whether I am an outlier.

8,735 up / 3,040 down74% upvoted40 commentsid 4ov6pd29 Sep 2025

40 comments

6 in this archive, depth 2

best — the order this archive was captured in

u/receptor_bias_rick965 points·10 months ago

press release SELECT posts must be flaired until a publication exists

replysharereportpermalink
u/cloudy_vial_carol406 points·10 months ago

press release SELECT posts must be flaired until a publication exists

Disagree on that part. 96.2% and 96.8% on the same vial is normal.

replysharereportpermalink
u/anders_vermeulen673 points·10 months ago

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

replysharereportpermalink
u/emil_agyeman434 points·10 months ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/forest_plot_fionaMOD232 points·10 months ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/formulary_fighterappeals334 points·10 months ago

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

replysharereportpermalink
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →